Navigation Links
Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway

o discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE(R), was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on The Nasdaq Global Market under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.

FORWARD-LOOKING STATEMENT

The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this press release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the timing and scope of clinical studies and trials for nab-rapamycin mTOR inhibitor (ABI 009), and nab-17AAG HSP90 inhibitor (ABI 010). Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the fact that results from pre-clinical studies may not be predictive of results to be obtained in other pre-clinical studies and future clinical trials, delays in commencement and completion of clinical trials, including slower than anticipated patient enrollment and adverse events occurring during the clinical trials, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing, the availability and pricing of ingredients used in the manufacture of pharmaceutical products, the ability to successfully manufacture products in a time-sensitive and cost effective manner, the acceptance and demand of new pharmaceutical products, the impact of patents and other proprietary rights held by competitors and other third parties. Additional
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycins Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
2. Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (Abraxane) with Anti-Angiogenic Agents to Increase Tumor Response
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
5. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
6. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
7. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
8. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
9. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
10. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
11. IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation
Post Your Comments:
(Date:7/29/2014)... , July 29, 2014 According ... Research "Orthopedic Trauma Fixation Devices Market - Global Forecast, ... 2020", the global orthopedic trauma fixation devices market is ... expected to grow at a CAGR of 7.2% from ... USD 9.3 billion in 2020. Browse the ...
(Date:7/29/2014)... 29, 2014  Sysmex America, Inc., a global leader ... will feature an exhibit booth during the American ... Lab Expo in Chicago , ... "We are extremely excited to exhibit at AACC this ... our customers and continue the dialogue on how to ...
(Date:7/29/2014)... 2014   What:   ... present data from a Phase I clinical trial of ... stop Parkinson,s disease progression. The Michael J. Fox Foundation ... will discuss the impact of the results for patients ... July 31, 2014         ...
Breaking Medicine Technology:Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 2Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 3Orthopedic Trauma Fixation Devices Market is Expected to Reach USD 9.3 Billion Globally in 2020: Transparency Market Research 4New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3Reminder/Media Advisory/AFFiRiS AG Presents Early Clinical Data on a First-of-its-Kind Parkinson's Disease Vaccine 2
... Dec. 17, 2010 Northwestern Memorial Hospital , ... today announced the renewal of its Magnet status, the ... by the American Nurses Credentialing Center (ANCC) and recognizes ...  The ANCC notified Northwestern Memorial of the decision Tuesday, ...
... Dec. 17, 2010 Cardinal Health today announced that ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... a leading pharmaceutical distributor serving the New York metropolitan ... shortly. About Cardinal Health ...
Cached Medicine Technology:Northwestern Memorial Maintains Top Status in Nursing Hospital Renewed for Nurse Magnet® 2Northwestern Memorial Maintains Top Status in Nursing Hospital Renewed for Nurse Magnet® 3Cardinal Health Receives Regulatory Clearance for Kinray Acquisition 2Cardinal Health Receives Regulatory Clearance for Kinray Acquisition 3
(Date:7/29/2014)... Calif. (PRWEB) July 29, 2014 July ... drug abuse directly at the source? That’s the big ... an innovative prescription drug abuse risk program developed by ... hundreds of applicants worldwide to be part of ... 10-12 in San Francisco, CA. The Hive is a ...
(Date:7/29/2014)... should significantly reform the federal system for financing ... the public,s $15 billion annual investment is producing ... new report by the Institute of Medicine. ... requires little accountability, allocates funds independent of workforce ... to train physicians in the health care settings ...
(Date:7/29/2014)... HealthDay Reporter MONDAY, July 28, 2014 ... to rage throughout West Africa poses little risk to Americans, ... physical touch, and it can,t be spread by people who ... the National Center for Emerging & Zoonotic Infectious Diseases at ... a Monday afternoon news conference. Those factors -- and ...
(Date:7/29/2014)... July 29, 2014 – Silverado, a provider of ... announce that it is a Bronze winner in the 35th ... Silverado Through a Child's Eye and Silverado Resident ... Through a Child's Eye , seven-year-old Mia Sandoval shares her ... Place, a memory care community in Los Angeles. The feel-good ...
(Date:7/29/2014)... July 29, 2014 Doug and Sandra Williams ... years and selling their grow-your-own log kits for almost that ... Williams’ diet and a treat for their guests. A ... perspective to the Lost Creek Mushroom Farm online coverage. , ... chefs, but soon turned to selling the logs instead of ...
Breaking Medicine News(10 mins):Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 2Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 3Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 2Health News:$15 billion annual public funding system for doctor training needs overhaul, says IOM 3Health News:CDC Downplays Ebola's Threat to the United States 2Health News:CDC Downplays Ebola's Threat to the United States 3Health News:CDC Downplays Ebola's Threat to the United States 4Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 4
... ... aftershave, beard inhibitor, and SPF29 sun block spray. , ... (PRWEB) January 27, 2010 -- Hey Dude Skin Care ™, ... an outstanding array of premium skin care products targeted at the unique protection, repair and ...
... CHAIRMAN , NEW YORK , Jan. 27 ... University announced today that William H. Foster , PhD, Dean ... Service, will become President and Chief Executive Officer of CASA on ... former U.S. Secretary of Health, Education, and Welfare who founded CASA in ...
... , , PHOENIX ... Eating and Anxiety Disorders ( http://www.remudaranch.com ) and MASK (Mothers ... teachers and students about eating disorders and related issues. , ... trained by an organization of the caliber of Remuda Ranch," ...
... , , NEW YORK , Jan. 27 ... $250,000 grant to the Clinton Health Access Initiative (CHAI), a ... in 2002. The grant will ensure the continuation of HIV/AIDS ... of the devastating January 12 earthquake. , ...
... , , LOS ANGELES , Jan. 27 ... more information about the IDEAL breast implants on his blog. He discussed ... would be available to the public for a clinical trial. , Board-certified ... of the new IDEAL breast implants. These implants are known to have ...
... woman who suggests using a condom makes no difference to ... suggests it makes a difference. If she highlights her sexuality ... and fun activity, other women judge her more harshly than ... or shares her concerns about sexually transmitted infections. Dr. Michelle ...
Cached Medicine News:Health News:Hey Dude Skin Care™ Rolls Out Line of Premium Men's Skin Care Products 2Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 2Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 3Health News:William H. Foster Succeeds Califano as President and CEO of CASA* 4Health News:Remuda Ranch, Programs for Eating and Anxiety Disorders, and MASK (Mothers Awareness on School-Age Kids), Partner to Help Educate Parents, Teachers and Students About Eating Disorders 2Health News:Remuda Ranch, Programs for Eating and Anxiety Disorders, and MASK (Mothers Awareness on School-Age Kids), Partner to Help Educate Parents, Teachers and Students About Eating Disorders 3Health News:Ford Foundation Commits $250,000 to Support HIV/AIDS Services in Haiti 2Health News:Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants 2Health News:Dr. Jay Calvert MD Announces Details on New Patent-Protected Investigational Breast Implants 3Health News:Condom or no condom? It's not what you say, it's how you say it 2
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Inquire...
Medicine Products: